Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group Co's EBIT per Share for the
six
months ended in Feb. 2026 was 円277.46.
Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 was 円565.15.
During the past 12 months, the average EBIT per Share Growth Rate of Medical Ikkou Group Co was 5.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 24.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 2.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medical Ikkou Group Co's EBIT per Share or its related term are showing as below:
TSE:3353'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.9 Med: 1.4 Max: 24
Current: 24
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Medical Ikkou Group Co was 24.00% per year. The lowest was -10.90% per year. And the median was 1.40% per year.
TSE:3353's 3-Year EBIT Growth Rate is ranked better than 72.67% of 461
companies
in the Conglomerates industry
Industry Median: 8.5
vs TSE:3353: 24.00
Medical Ikkou Group Co (TSE:3353) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medical Ikkou Group Co EBIT per Share Related Terms
Medical Ikkou Group Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Medical Ikkou Group Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円565.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co (TSE:3353) has a EBIT per Share of 円565.15 as of Feb. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medical Ikkou Group Co and its competitors. According to the industry distribution chart, Medical Ikkou Group Co ranks #126 out of 461 companies in the Conglomerates industry, placing it in the top 27.3%.
Is Medical Ikkou Group Co's EBIT per Share too high?
Medical Ikkou Group Co's current EBIT per Share is 円565.15. Based on the distribution chart, Medical Ikkou Group Co ranks #126 out of 461 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's EBIT per Share compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #126 out of 461 companies for EBIT per Share. This puts Medical Ikkou Group Co in the upper half of its industry. The industry median EBIT per Share is 8.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Conglomerates company?
The median EBIT per Share among Conglomerates companies is 8.50, based on 461 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median EBIT per Share is 8.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current EBIT per Share is 円565.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,535.59, compared to a current price of 円2,816.00 — trading 20.4% below its estimated fair value. The current EBIT per Share is 円565.15. Medical Ikkou Group Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current EBIT per Share is 円565.15 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,816.00 is trading 20.4% below its estimated GF Value™ of 円3,535.59.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
EBIT per Share: 円565.15
GF Value™: 円3,535.59 vs. price of 円2,816.00 (20.4% below fair value)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
63GF Score
Get the complete analysis for TSE:3353
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
